Closed on weekends
Immune cell therapy technology involves collecting a small amount of venous blood from a tumor patient, isolating mononuclear cells in a GMP cell laboratory, and adding a series of cytokines for induction, enabling the immune cells to recognize tumor cells while increasing their number by over 1000 times and enhancing their bactericidal capacity. Then, the […]
Currently, autologous CIK cells are commonly used in the clinical treatment of tumors. However, for the vast majority of patients undergoing autologous CIK cell therapy, the clinical efficacy is unsatisfactory. Data indicate that the effective rate of autologous CIK cell therapy for various malignant solid tumors is between 3.9% and 30%, averaging below 30%. Preliminary […]